RESUMEN

Interleukin-1 alpha (IL-1 alpha) is secreted by a variety of cell types and is a major player in immune and inflammatory processes. Genes involved in immunological processes are known to be strictly regulated; however, how epigenetic mechanisms contribute to this regulation in not understood. To gain insight into the epigenetic regulation of the human TATA-less IL-1A gene, we show that active and silent chromatin modifications characterize the regulatory regions of IL-1 alpha in expressing and non-expressing cells, respectively, and that the DNA methylation in the proximal promoter is associated with the expression status of the cells. Interestingly, although nucleosome depletion in active promoters is found in yeast and fly genes, now it has been reported in human promoters. We here show on the level of single DNA molecules that in expressing cells, a nucleosome is absent in about half of the proximal IL-1 alpha promoters. This observation might reflect a more subtle regulation of nucleosome positioning in TATA-less genes or human genes in general.

Asunto(s)

Epigénesis Genética/inmunología , Interleucina-1alfa/genética , Nucleosomas/metabolismo , Regiones Promotoras Genéticas , TATA Box/genética , Línea Celular , Ensamble y Desensamble de Cromatina/genética , Ensamble y Desensamble de Cromatina/inmunología , Metilación de ADN/inmunología , Regulación de la Expresión Génica/inmunología , Humanos , Interleucina-1alfa/biosíntesis , Nucleosomas/genética , Nucleosomas/inmunología , Regiones Promotoras Genéticas/inmunología , TATA Box/inmunología

RESUMEN

We aimed to link DNA methylation events occurring in cervical carcinomas to distinct stages of HPV-induced transformation. Methylation specific-multiplex ligation-dependent probe amplification (MS-MLPA) analysis of cervical carcinomas revealed promoter methylation of 12 out of 29 tumour suppressor genes analysed, with MGMT being most frequently methylated (92%). Subsequently, consecutive stages of HPV16/18-transfected keratinocytes (n=11), ranging from pre-immortal to anchorage-independent phenotypes, were analysed by MS-MLPA. Whereas no methylation was evident in pre-immortal cells, progression to anchorage independence was associated with an accumulation of frequent methylation events involving five genes, all of which were also methylated in cervical carcinomas. TP73 and ESR1 methylation became manifest in early immortal cells followed by RARbeta and DAPK1 methylation in late immortal passages. Complementary methylation of MGMT was related to anchorage independence. Analysis of nine cervical cancer cell lines, representing the tumorigenic phenotype, revealed in addition to these five genes frequent methylation of CADM1, CDH13 and CHFR. In conclusion, eight recurrent methylation events in cervical carcinomas could be assigned to different stages of HPV-induced transformation. Hence, our in vitro model system provides a valuable tool to further functionally address the epigenetic alterations that are common in cervical carcinomas.

Asunto(s)

Adenocarcinoma/genética , Adenocarcinoma/virología , Carcinoma de Células Escamosas/genética , Carcinoma de Células Escamosas/virología , Infecciones por Papillomavirus/genética , Neoplasias del Cuello Uterino/genética , Neoplasias del Cuello Uterino/virología , Adenocarcinoma/patología , Carcinoma de Células Escamosas/patología , Línea Celular Tumoral , Metilación de ADN , ADN de Neoplasias/genética , ADN de Neoplasias/aislamiento & purificación , Femenino , Perfilación de la Expresión Génica , Humanos , Técnicas de Amplificación de Ácido Nucleico/métodos , Infecciones por Papillomavirus/complicaciones , Reacción en Cadena de la Polimerasa/métodos , Regiones Promotoras Genéticas/genética , Sensibilidad y Especificidad , Neoplasias del Cuello Uterino/patología

RESUMEN

Interleukin-12 (IL-12) is a potent inducer of interferon-gamma production by T cells and is a major factor for the development of T-helper 1 (Th1) cells. It exerts its biological effects through binding to the IL-12 receptor (IL-12R), a heterodimer composed of a 1 and a beta2 subunits. The signaling beta2 chain is expressed on Th1 cells and to a lesser extent on Th0 cells, but not on Th2 cells, rendering these latter cells unresponsive to IL-12. Polymorphisms in the coding region of the IL-12Rbeta2 gene were shown to be associated with atopic disease. Here, we analyzed the 5'-regulatory region of the human IL-12Rbeta2 gene by denaturing high-performance liquid chromatography (Transgenomic WAVE system, San Jose, CA). We found five novel single-nucleotide polymorphisms (SNPs) in the proximal 1.2 kb IL-12Rbeta2 promoter region, i.e. -237C/T, -465A/G, -1023A/G, -1033T/C, and -1035A/G. SNP -465A/G is of particular interest as it determines the integrity of a GATA consensus site. By functional comparison of both -465 alleles in transient transfection assays, we show that promoter activity is increased in case of the -465G allele, disrupting the intact GATA site. Comparison of the prevalence of -465A/G SNP alleles in small cohorts of allergic asthmatic and healthy control individuals provided no evidence for an altered distribution in the asthmatic population. In conclusion, we have identified a novel polymorphic GATA site that may affect transciptional activity of the human IL-12Rbeta2 gene under GATA3-mediated, Th2-polarizing conditions.

Asunto(s)

Regiones Promotoras Genéticas , Receptores de Interleucina/genética , Región de Flanqueo 5' , Asma/genética , Secuencia de Bases , Secuencia de Consenso , Humanos , Datos de Secuencia Molecular , Polimorfismo de Nucleótido Simple , Receptores de Interleucina-12

RESUMEN

BACKGROUND: Expression of signal transducer and activator of transcription 1 (STAT1), the mediator of interferon (IFN) signalling, is raised in synovial tissue (ST) from patients with rheumatoid arthritis (RA). OBJECTIVES: To determine the extent to which this pathway is activated by phosphorylation in RA synovium. Additionally, to investigate the cellular basis of STAT1 activation in RA ST. METHODS: ST specimens from 12 patients with RA and 14 disease controls (patients with osteoarthritis and reactive arthritis) were analysed by immunohistochemistry, using antibodies to STAT1, tyrosine phosphorylated STAT1, and serine phosphorylated STAT1. Lysates of cultured fibroblast-like synoviocytes stimulated with IFNbeta were analysed by western blotting. Phenotypic characterisation of cells expressing STAT1 in RA ST was performed by double immunolabelling for STAT1 and CD3, CD22, CD55, or CD68. RESULTS: Raised levels of total STAT1 protein and both its activated tyrosine and serine phosphorylated forms were seen in RA synovium as compared with controls. STAT1 was predominantly abundant in T and B lymphocytes in focal inflammatory infiltrates and in fibroblast-like synoviocytes in the intimal lining layer. Raised levels of STAT1 are sustained in cultured RA compared with OA fibroblast-like synoviocytes, and STAT1 serine and tyrosine phosphorylation is rapidly induced upon stimulation with IFNbeta. CONCLUSION: These results demonstrate activation of the STAT1 pathway in RA synovium by raised STAT1 protein expression and concomitantly increased tyrosine (701) and serine (727) phosphorylation. High expression of STAT1 is intrinsic to RA fibroblast-like synoviocytes in the intimal lining layer, whereas activation of the pathway by phosphorylation is an active process.

Asunto(s)

Artritis Reumatoide/metabolismo , Proteínas de Unión al ADN/análisis , Transducción de Señal/fisiología , Membrana Sinovial/metabolismo , Transactivadores/análisis , Adulto , Anciano , Anciano de 80 o más Años , Artritis Reactiva/metabolismo , Western Blotting/métodos , Células Cultivadas , Femenino , Humanos , Inmunohistoquímica/métodos , Interferón beta/farmacología , Masculino , Microscopía Fluorescente , Persona de Mediana Edad , Osteoartritis/metabolismo , Fosforilación , Factor de Transcripción STAT1 , Estimulación Química

RESUMEN

Interleukin 12 (IL-12) is a potent enhancer of interferon gamma production by activated T cells. The high-affinity IL-12 receptor (IL-12R) is a heterodimer of a beta1 and a beta2 subunit. Expression of the signaling IL-12Rbeta2 chain is usually low, as compared with the more abundant beta1 chain, and may be rate-limiting for IL-12 sensitivity. Little is known about the mechanisms controlling IL-12Rbeta2 gene expression. Reporter gene assays in IL-12Rbeta2-expressing Jurkat cells showed that truncation of the region from -151 to -61 abrogated promoter activity. The proximal promoter region does not contain a typical TATA box, suggesting a role for SP-1. Indeed, mutagenesis of the -63 SP-1 consensus site decreased transcription by 50%. Electrophoretic mobility shift experiments confirmed the binding of SP-1 and SP-3 at this site. In contrast, truncation of -252 to -192 increased promoter activity. Likewise, mutagenesis of the consensus nuclear factor of activated T cells site at -206 increased promoter activity by 70%, suggesting silencer activity of this element. Electrophoretic mobility shift experiments with primary Th (T helper) cells showed the formation of a specific, T-cell receptor-inducible complex at this site that is sensitive to cyclosporin A and supershifted with anti-NFATc2 in both Th1 and Th2 cells. Accordingly, cyclosporin A dose-dependently increased IL-12Rbeta2 mRNA expression. These first data on IL-12Rbeta2 gene regulation indicate a TATA-less promoter, depending on SP-1/SP-3 transcription factors, and a negative regulatory NFAT element at -206. This element may contribute to the overall low level of IL-12Rbeta2 expression on Th cells.

Asunto(s)

Proteínas de Unión al ADN/fisiología , Silenciador del Gen , Proteínas Nucleares , Podofilino/análogos & derivados , Regiones Promotoras Genéticas , Receptores de Interleucina/genética , Linfocitos T Colaboradores-Inductores/metabolismo , Factores de Transcripción/fisiología , Secuencia de Bases , Sitios de Unión , Regulación de la Expresión Génica , Genes Reguladores , Humanos , Células Jurkat , Datos de Secuencia Molecular , Factores de Transcripción NFATC , Podofilino/metabolismo , Podofilotoxina/análogos & derivados , Subunidades de Proteína , ARN Mensajero/análisis , Receptores de Interleucina-12

RESUMEN

IL-12 is a potent inducer of IFN-gamma production and drives the development of Th1 cells. Human polarized Th2 cells do not express the signaling beta2-subunit of the IL-12R and, therefore, do not signal in response to IL-12. The question was raised as to what extent the loss of the IL-12Rbeta2 chain in Th2 cells has bearing on the stability of the human Th2 phenotype. In the present report, we show that restimulation of human fully polarized Th2 cells in the presence of IL-12 primes for a shift towards Th0/Th1 phenotypes, accompanied by suppression of GATA-3 expression and induction of T-bet expression. These reversed cells are further characterized by a marked IL-12Rbeta2 chain expression and fully restored IL-12-inducible STAT4 activation. The IL-12-induced phenotypic shift proved to be stable as a subsequent restimulation in the presence of IL-4 and in the absence of IL-12 could not undo the accomplished changes. Identical results were obtained with cells from atopic patients, both with polyclonal Th2 cell lines and allergen-specific Th2 cell clones. These findings suggest the possibility of restoring IL-12 responsiveness in established Th2 cells of atopic patients by stimulation in the presence of IL-12, and that IL-12-promoting immunotherapy can be beneficial for Th2-mediated immune disorders, targeting both naive and memory effector T cells.

Asunto(s)

Proteínas de Unión al ADN/metabolismo , Interleucina-12/farmacología , Células Th2/efectos de los fármacos , Células Th2/metabolismo , Transactivadores/metabolismo , Alérgenos/inmunología , Anticuerpos Monoclonales , Diferenciación Celular/efectos de los fármacos , Células Cultivadas , Células Clonales/efectos de los fármacos , Células Clonales/inmunología , Células Clonales/metabolismo , Proteínas de Unión al ADN/genética , Citometría de Flujo , Factor de Transcripción GATA3 , Regulación de la Expresión Génica/efectos de los fármacos , Humanos , Hipersensibilidad/inmunología , Inmunohistoquímica , Inmunoterapia , Interferón gamma/inmunología , Interferón gamma/metabolismo , Interleucina-12/inmunología , Interleucina-4/inmunología , Interleucina-4/metabolismo , Interleucina-4/farmacología , Activación de Linfocitos , Fenotipo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Receptores de Interleucina/metabolismo , Receptores de Interleucina-12 , Factor de Transcripción STAT4 , Transducción de Señal/efectos de los fármacos , Proteínas de Dominio T Box , Células TH1/efectos de los fármacos , Células TH1/inmunología , Células TH1/metabolismo , Células Th2/inmunología , Transactivadores/genética , Factores de Transcripción/genética

RESUMEN

CD40 belongs to the tumor necrosis factor (TNF) receptor family. CD40 signaling involves the recruitment of TNF receptor-associated factors (TRAFs) to its cytoplasmic domain. We have identified a novel intracellular CD40-binding protein termed TRAF and TNF receptor-associated protein (TTRAP) that also interacts with TNF-R75 and CD30. The region of the CD40 cytoplasmic domain that is required for TTRAP association overlaps with the TRAF6 recognition motif. Association of TTRAP with CD40 increases profoundly in response to treatment of cells with CD40L. Interestingly, TTRAP also associates with TRAFs, with the highest affinity for TRAF6. In transfected cells, TTRAP inhibits in a dose-dependent manner the transcriptional activation of a nuclear factor-kappaB (NF-kappaB)-dependent reporter mediated by CD40, TNF-R75 or Phorbol 12-myristate 13-acetate (PMA) and to a lesser extent by TRAF2, TRAF6, TNF-alpha, or interleukin-1beta (IL-1beta). TTRAP does not affect stimulation of NF-kappaB induced by overexpression of the NF-kappaB-inducing kinase (NIK), the IkappaB kinase alpha (IKKalpha), or the NF-kappaB subunit P65/RelA, suggesting it acts upstream of the latter proteins. Our results indicate that we have isolated a novel regulatory factor that is involved in signal transduction by distinct members of the TNF receptor family.

Asunto(s)

Antígenos CD/metabolismo , Proteínas Bacterianas/metabolismo , Antígenos CD40/metabolismo , Proteínas Portadoras/metabolismo , FN-kappa B/antagonistas & inhibidores , Receptores del Factor de Necrosis Tumoral/metabolismo , Secuencia de Aminoácidos , Animales , Caenorhabditis elegans , Clonación Molecular , Humanos , Quinasa I-kappa B , Ratones , Datos de Secuencia Molecular , FN-kappa B/metabolismo , Proteínas Serina-Treonina Quinasas/metabolismo , Proteínas/metabolismo , Receptores Tipo II del Factor de Necrosis Tumoral , Alineación de Secuencia , Transducción de Señal , Factor 6 Asociado a Receptor de TNF , Acetato de Tetradecanoilforbol/metabolismo , Factor de Transcripción ReIA , Xenopus , Quinasa de Factor Nuclear kappa B

RESUMEN

The interleukin-12 receptor (IL-12R) is composed of two subunits, referred to as beta1 and beta2. Both chains are necessary for high-affinity IL-12 binding and signalling, although only the IL-12Rbeta2 chain contains the intracellular tyrosine residues responsible for STAT4 activation. This study presents the intron-exon organization of the human IL-12Rbeta2-chain gene. Polymerase chain reaction (PCR) primers designed across the cDNA (U46198) were used to trace introns, by comparing PCR product sizes obtained using cDNA and genomic DNA as templates. PCR products spanning introns were sequenced to determine the exact splice sites and flanking regions. The coding region of the gene was found to consist of 15 exons and 14 introns. All intron-exon boundaries are consistent with the consensus sequence for splice junctions (5' GT/AG 3'). Comparison of the intron-exon organization with the human GCSFR gene indicated a remarkably well conserved genomic organization between these two class I cytokine receptors. Interestingly, we identified an alternatively spliced mRNA, encoding a putative, truncated protein, lacking all signalling potential.

Asunto(s)

Exones/genética , Intrones/genética , Receptores de Interleucina/genética , Empalme Alternativo/genética , Secuencias de Aminoácidos/genética , Secuencia de Aminoácidos , Secuencia de Bases , Células Cultivadas , Codón de Terminación/genética , Secuencia Conservada/genética , Cartilla de ADN/genética , ADN Complementario/genética , Humanos , Reacción en Cadena de la Polimerasa , ARN Mensajero/análisis , ARN Mensajero/genética , Receptores de Interleucina/química , Receptores de Interleucina/fisiología , Receptores de Interleucina-12 , Eliminación de Secuencia/genética , Linfocitos T/metabolismo , Tirosina/genética